Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
The mechanism by which PI3 kinase/mTOR inhibition increases sensitivity of oestrogen receptor (ER)-positive breast cancers to CDK4/6 inhibition is by blocking cell cycle re-entry driven by cyclin D1 and by inducing apoptosis, according to findings presented during a session at the IMPAKT Breast Cancer Conference held 7–9 May 2015 in Brussels, Belgium.
Click here to read the article in full.
Source: ESMO
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.